Siu M.K.; Abou-Kheir W.; Yin J.J.; Chang Y.-S.; Barrett B.; Suau F.; Casey O.; Chen W.-Y.; Fang L.; Hynes P.; Hsieh Y.-Y.; Liu Y.-N.; Huang J.; Kelly K.
(Impact Journals LLC; ALBANY6211 TIPTON HOUSE, STE 6, ALBANY, NY 12203 USA, 2014)
Activation of EGFR signaling pathway leads to prostate cancer bone metastasis; however, therapies targeting EGFR have demonstrated limited effectiveness and led to drug resistance. miR-203 levels are down-regulated in ...